Medical Biomimetics Market, By Product Type, Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Biomimetics are used for development of biocompatible material which allows healthcare professionals to monitor and treat chronic diseases such as cardiovascular disorders. Biomimetics have application in regenerative medicine, tissue engineering, and drug delivery. Incorporation of nanotechnology played a pivotal role for application in bone structures as well as drug delivery systems.

Market Dynamics

The increasing incidence of cardiovascular disorders, demand for prosthetics, implants for organ transplant, adoption of expansion strategies by manufacturers, product launches, along with the rising healthcare expenditure in developed and developing economies are the major factors driving the global medical biomimetic market growth. For instance, according to the Center for Medicare and Medicaid Center, healthcare spending grew by 4.6% in 2018 compared to 2017 and reached around US$ 3.6 Trillion in the U.S.

Furthermore, adoption of inorganic strategies such as mergers and acquisitions, expansion of production capabilities, new product development by key players for expanding their product portfolio in the market is expected to drive the market growth. For instance, in November 2021, Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies announced opening of new production facility in Gaithersburg, Maryland.

Key features of the study:

• This report provides in-depth analysis of the global medical biomimetic market and provides market size (US$ billion) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global medical biomimetic market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study are AVINENT Science and Technology, SynTouch Inc., Wright Medical Group N.V., EP Endovascular AB, Varian Medical Systems, Inc., Aboott, Osteopore International Pte Ltd., and Applied Biomimetic.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global medical biomimetic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical biomimetic market.

Detailed Segmentation:

• Global Medical Biomimetics Market, By Product Type:
  • Cardiovascular
  • Ophthalmology
  • Dental
  • Orthopedic
  • Others
• Global Medical Biomimetics Market , By Application:
  • Wound Healing
  • Plastic Surgery
  • Drug Delivery
  • Others
• Global Medical Biomimetics Market , By Region:
  • North America
    • By Product Type:
    • Cardiovascular
    • Ophthalmology
    • Dental
    • Orthopedic
    • Others
    • By Application:
    • Wound Healing
    • Plastic Surgery
    • Drug Delivery
    • Others
    • By Country:
    • U.S.
    • Canada
  • Latin America
    • By Product Type:
    • Cardiovascular
    • Ophthalmology
    • Dental
    • Orthopedic
    • Others
    • By Application:
    • Wound Healing
    • Plastic Surgery
    • Drug Delivery
    • Others
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Product Type:
    • Cardiovascular
    • Ophthalmology
    • Dental
    • Orthopedic
    • Others
    • By Application:
    • Wound Healing
    • Plastic Surgery
    • Drug Delivery
    • Others
    • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Product Type:
    • Cardiovascular
    • Ophthalmology
    • Dental
    • Orthopedic
    • Others
    • By Application:
    • Wound Healing
    • Plastic Surgery
    • Drug Delivery
    • Others
    • By Country:
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Product Type:
    • Cardiovascular
    • Ophthalmology
    • Dental
    • Orthopedic
    • Others
    • By Application:
    • Wound Healing
    • Plastic Surgery
    • Drug Delivery
    • Others
    • By Country:
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Product Type:
    • Cardiovascular
    • Ophthalmology
    • Dental
    • Orthopedic
    • Others
    • By Application:
    • Wound Healing
    • Plastic Surgery
    • Drug Delivery
    • Others
    • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • AVINENT Science and Technology*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Highlights
    • Market Strategies
  • SynTouch Inc.
  • Wright Medical Group N.V.
  • EP Endovascular AB
  • Varian Medical Systems, Inc.
  • Abbott
  • Osteopore International Pte Ltd.
  • Applied Biomimetic.

"*" marked represents similar segmentation in other categories in the respective section.